Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: mm meri showed up, accumulated and left

Re: CAUTIOUS, the quarters after settlement

posted on Dec 03, 2007 08:09AM

Thanks for the clarification. 

Your comments are exactly what I meant - not all 400 need to be signed in a few quarters. We just need a significantly higher rate of signings. How many signings doesn't matter as much as the $ revenue. It needs to be enough $ to keep the revenue close to or better than the settlement quarter, IMO, if they are to realize and sustain a higher PPS ($15+) and the high P/E this stock deserves.

As I said, this should be doable with good capacity planning and process execution.

 

Share
New Message
Please login to post a reply